FDA approves first cell therapy to treat patients with type 1 diabetes
SILVER SPRING, Md., June 28, 2023 /PRNewswire/ — Today, the United States Food and Drug Administration approved Lantidra, the first allogeneic (donor) pancreatic islet cell therapy made from deceased donor pancreatic cells for the treatment of type 1 diabetes. the treatment of adults with type 1 diabetes who are unable to reach target glycated hemoglobin … Read more